These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 24732366)

  • 1. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.
    Gold MR; Weiss R; Theuns DA; Smith W; Leon A; Knight BP; Carter N; Husby M; Burke MC
    Heart Rhythm; 2014 Aug; 11(8):1352-8. PubMed ID: 24732366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.
    Olde Nordkamp LR; Brouwer TF; Barr C; Theuns DA; Boersma LV; Johansen JB; Neuzil P; Wilde AA; Carter N; Husby M; Lambiase PD; Knops RE
    Int J Cardiol; 2015 Sep; 195():126-33. PubMed ID: 26026928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.
    Mesquita J; Cavaco D; Ferreira A; Lopes N; Santos PG; Carvalho MS; Haas A; Costa F; Carmo P; Morgado F; Adragão P; Mendes M
    Int J Cardiol; 2017 Apr; 232():176-180. PubMed ID: 28082086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
    Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
    Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programming implantable cardioverter-defibrillator therapy zones to high ranges to prevent delivery of inappropriate device therapies in patients with primary prevention: results from the RISSY-ICD (Reduction of Inappropriate ShockS bY InCreaseD zones) trial.
    Cay S; Canpolat U; Ucar F; Ozeke O; Ozcan F; Topaloglu S; Aras D
    Am J Cardiol; 2015 May; 115(9):1235-43. PubMed ID: 25765588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator.
    Theuns DAMJ; Brouwer TF; Jones PW; Allavatam V; Donnelley S; Auricchio A; Knops RE; Burke MC
    Heart Rhythm; 2018 Oct; 15(10):1515-1522. PubMed ID: 29758404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of ENHANCED Implantable Cardioverter Defibrillator Programming to Reduce Therapies and Improve Quality of Life (from the ENHANCED-ICD Study).
    Mastenbroek MH; Pedersen SS; van der Tweel I; Doevendans PA; Meine M
    Am J Cardiol; 2016 Feb; 117(4):596-604. PubMed ID: 26732419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
    Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
    Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination-Implantable Cardioverter Defibrillator Study.
    Ruiz-Granell R; Dovellini EV; Dompnier A; Khalighi K; García-Campo E; Olivier A; Barcelo A; Ritter P
    Heart Rhythm; 2019 Sep; 16(9):1429-1435. PubMed ID: 30910709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial.
    Gold MR; Ahmad S; Browne K; Berg KC; Thackeray L; Berger RD
    Heart Rhythm; 2012 Mar; 9(3):370-7. PubMed ID: 21978966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SVT discrimination algorithms significantly reduce the rate of inappropriate therapy in the setting of modern-day delayed high-rate detection programming.
    Cheng A; Auricchio A; Schloss EJ; Kurita T; Sterns LD; Gerritse B; Brown ML; Fagan DH; Lexcen DR; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2877-2884. PubMed ID: 31646695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies.
    Garnreiter JM; Pilcher TA; Etheridge SP; Saarel EV
    Heart Rhythm; 2015 May; 12(5):937-42. PubMed ID: 25620047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study.
    Kutyifa V; Daubert JP; Schuger C; Goldenberg I; Klein H; Aktas MK; McNitt S; Stockburger M; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e001965. PubMed ID: 26743237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new algorithm to reduce inappropriate therapy in the S-ICD system.
    Brisben AJ; Burke MC; Knight BP; Hahn SJ; Herrmann KL; Allavatam V; Mahajan D; Sanghera R; Gold MR
    J Cardiovasc Electrophysiol; 2015 Apr; 26(4):417-423. PubMed ID: 25581303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study.
    Gilliam FR; Hayes DL; Boehmer JP; Day J; Heidenreich PA; Seth M; Jones PW; Stein KM; Saxon LA
    J Cardiovasc Electrophysiol; 2011 Sep; 22(9):1023-9. PubMed ID: 21627705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between detection rate and inappropriate shocks in single versus dual chamber cardioverter-defibrillator--an analysis from the OPTION trial.
    Kolb C; Sturmer M; Babuty D; Sick P; Davy JM; Molon G; Schwab JO; Mantovani G; Wickliffe A; Lennerz C; Semmler V; Siot PH; Reif S
    Sci Rep; 2016 Feb; 6():21748. PubMed ID: 26892534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.
    Kooiman KM; Knops RE; Olde Nordkamp L; Wilde AA; de Groot JR
    Heart Rhythm; 2014 Mar; 11(3):426-34. PubMed ID: 24321235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.